mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
Ofer Zimmerman(Washington University in St. Louis), Michael S. Diamond(Washington University in St. Louis), Harry L. Bertera(Ragon Institute of MGH, MIT and Harvard), Ali H. Ellebedy(Washington University in St. Louis), Fang Zhao(Washington University in St. Louis), Laura A. VanBlargan(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Chieh-Yu Liang(Washington University in St. Louis), Alexa Michelle Altman Doss(Washington University in St. Louis), Rita E. Chen(Washington University in St. Louis), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Tiffany Biason Dy(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Jennifer Monroy(Washington University in St. Louis), Zhen Ren(Washington University in St. Louis), Paulina Kapłonek(Moderna Therapeutics (United States)), Hannah G. Davis-Adams(Washington University in St. Louis), Peggy L. Kendall(Washington University in St. Louis), Caitlin C. O’Shaughnessy(Washington University in St. Louis), H. James Wedner(Washington University in St. Louis), Anthony Kulczycki(Washington University in St. Louis), Christopher J. Rigell(Washington University in St. Louis), Lucas J. Adams(Washington University in St. Louis), Saravanan Raju(Washington University in St. Louis), Andrew L. Kau(Washington University in St. Louis), Tarisa L. Mantia(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital)
Cited by 16
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981